We found that although there was an increase in Tregs infiltrating the tumor compared to tumors from control animals, the ratio of Treg/CD8+ T cells suggested a more cytotoxic tumor microenvironment and aligned with that observed in human subjects with better clinical outcomes [43]. The gene discussed is CD8A; the disease is neoplasm.